Home/Filings/4/0001169245-23-000028
4//SEC Filing

Loewy Caroline M 4

Accession 0001169245-23-000028

CIK 0001169245other

Filed

May 18, 8:00 PM ET

Accepted

May 19, 4:16 PM ET

Size

7.1 KB

Accession

0001169245-23-000028

Insider Transaction Report

Form 4
Period: 2023-05-19
Transactions
  • Exercise/Conversion

    Common Stock

    2023-05-19+3,7503,750 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-05-193,7500 total
    Common Stock (3,750 underlying)
Footnotes (2)
  • [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of PhaseBio Pharmaceuticals, Inc. common stock.
  • [F2]The RSUs vested and were delivered to the Reporting Person on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service through such date.

Issuer

PhaseBio Pharmaceuticals Inc

CIK 0001169245

Entity typeother

Related Parties

1
  • filerCIK 0001367451

Filing Metadata

Form type
4
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:16 PM ET
Size
7.1 KB